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Background: Sweden introduced a school-based human papillomavirus (HPV) vaccination programme in 2012, and
school nurses are responsible for managing the vaccinations. The aim of the present study was to investigate the
attitudes and experiences of school nurses regarding the school-based HPV vaccination programme 1 year after its
implementation.
Methods: Data were collected using a web-based questionnaire in the spring of 2013, and 83.1% (851/1024) of
nurses responded.
Results: There were strong associations between the nurses’ education about the HPV vaccine and their perceived
knowledge about the vaccine and a favourable attitude towards vaccination (both p < 0.001). School nurses who
received a high level of education were more likely to have a positive attitude to HPV vaccination compared with
nurses with little education about HPV vaccination (adjusted odds ratio [OR] = 9.8; 95% confidence interval [CI]:
3.797–25.132). Nurses with high perceived knowledge were more likely to have a positive attitude compared with
those with a low level of perceived knowledge (OR = 2.5; 95% CI: 1.299–4.955). If financial support from the
government was used to fund an additional school nurse, nurses were more likely to have a positive attitude than
if the financial support was not used to cover the extra expenses incurred by the HPV vaccination (OR = 2.1; 95% CI:
1.051–4.010). The majority, 648 (76.1%), had been contacted by parents with questions about the vaccine, mostly
related to adverse effects. In addition, 570 (66.9%) stated that they had experienced difficulties with the
vaccinations, and 337 (59.1%) of these considered the task to be time-consuming.
Conclusions: A high level of education and perceived good knowledge about HPV are associated with a positive
attitude of school nurses to the HPV vaccination programme. Thus, nurses require adequate knowledge, education,
skills and time to address the questions and concerns of parents, as well as providing information about HPV.
Strategic financial support is required because HPV vaccination is a complex and time-consuming task.
Keywords: Attitude, Experience, Human papillomavirus, School health, School nurse, VaccinationBackground
Human papillomavirus (HPV) vaccination programmes for
girls aged 9–14 years have been implemented in many
countries worldwide [1,2]. Implementation strategies vary
between countries because of different healthcare policies.
In the United States as well as in several European coun-
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unless otherwise stated.health centres. In other countries, such as Australia,
Canada and the United Kingdom, vaccination is performed
in schools [3]. The vaccination uptake rate for three doses
differs between countries, but it is in general highest in lo-
cations and countries where school-based vaccination pro-
grammes have been implemented [3,4], varying from about
70% in Australia [5] to 84% in the United Kingdom [6].
In 2012, the quadrivalent HPV vaccine was introduced
in a Swedish school-based vaccination programme for
girls aged 10–12 years. The first-year coverage for at least
one dose was 79% [7]. All school-based vaccinations areal Ltd. This is an Open Access article distributed under the terms of the Creative
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School nurses are responsible for managing all aspects of
the vaccinations, including the logistics, providing informa-
tion to parents and girls, and administration of the vaccine.
The information distributed to parents is standardised by
the National Board of Health and Welfare, which ensures
that all parents receive equal and uniform information [8].
It is recommended that school nurses work in pairs during
vaccination to facilitate the management of adverse reac-
tions. After receiving the injected vaccine, the girls are
observed for at least 15 minutes. As school nurses gener-
ally work alone, an extra nurse is required during vaccina-
tions, and this is arranged by employing an additional
nurse or by school nurses providing reciprocal cover with
a colleague in a school nearby. To compensate the School
Health Services for this increased workload, the Swedish
Government has provided extra financial support to the
municipalities. The principal of each school is responsible
for the distribution of this funding.
The perceptions of Swedish school nurses regarding the
HPV vaccination programme were explored during focus
group interviews before its implementation [9]. The school
nurses considered that the vaccine would be beneficial, but
they had doubts about its safety. They were also concerned
about their workload, as well as how they would inform
about HPV and obtain informed consent. In general, the
school nurses supported the implementation, and they be-
lieved that it would decrease inequalities between families
of different socioeconomic status [9]. In the United
Kingdom, where the school-based vaccination programme
started in 2008, school nurses believed that HPV vaccin-
ation was a way to minimise health inequalities, although
the procedure gave them less time for other crucial respon-
sibilities, such as supporting vulnerable pupils [10,11].
An efficient vaccination programme is important to
achieve high coverage, and school nurses play a key role
in the success of school-based HPV vaccination pro-
grammes. Thus, the aim of the present study was to inves-
tigate the attitudes and experiences of school nurses
regarding the school-based HPV vaccination programme
1 year after its implementation in Sweden.
Hypothesis
The hypothesis was that there would be associations
between school nurses (i) perceived knowledge of HPV
vaccinations, (ii) the education they received about HPV,
and (iii) the financial support given to the School Health
Services, on one hand, and the attitudes of school nurses
to the HPV vaccination programme on the other hand.
Methods
Design
A cross-sectional web-based survey was carried out in
Sweden between March and May 2013. The school nurseseligible for inclusion were those who participated in the
school-based HPV vaccination programme. At the time of
the study, there were 2438 registered school nurses in
Sweden, and 1024 worked in the 5th and 6th grades (chil-
dren aged 10–12 years), which were the ages included in
the school-based HPV vaccination programme.
Procedure
Nurses were recruited via the official website of the Swedish
Association of School Nurses. One of the researchers
(CS) sent an email explaining the study’s aim and proce-
dures to all heads of the School Health Services, as well as
a request to inform the school nurses in each municipality
about the study and to invite them to participate. More in-
formation was available on the website, including a state-
ment that participation in the study was voluntary and
confidential. Those who agreed to participate were asked
to complete the web-based questionnaire. Reminders were
sent by email to the heads of the School Health Services
on two occasions, 2 and 4 weeks after the first invitation.
The study was approved by the Regional Ethical Review
Board in Uppsala, Sweden.
Questionnaire
The questionnaire was based on previous studies [9,12]
and clinical experience. The first part captured back-
ground demographic data, with questions about age, sex,
years of experience as a school nurse, responsible school
authority (public or private), which county they worked
in, and also the geographical area (rural, semi-urban or
urban). The main part of the questionnaire comprised
questions about the education and support given to
nurses before programme implementation, information
provided to families by the school nurse and the school
nurse’s perceived knowledge of, and attitude towards,
HPV vaccination. The questions had multiple choice al-
ternatives, which were rated using four-point scales that
ranged from “strongly agree” to “strongly disagree”. The
validity of the questionnaire [13] was tested using a
group of 10 school nurses, who were asked to assess the
relevance of the questions and to indicate whether they
experienced any difficulties or ambiguity during its com-
pletion. Some revisions were made, and the final version
comprised 26 questions, including two open-ended
questions that asked participants to state the most com-
mon question asked by parents and to describe their
perceived difficulties with HPV vaccinations. These
open-ended questions were analysed by systematically
organising and categorising the answers. The qualitative
components of this study adheres to the RATS guide-
lines for reporting qualitative studies.
The outcome in the present study, attitude towards
HPV vaccination, was based on two questions: (i) whether
the school nurses agreed that the introduction of HPV
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programme was appropriate; and (ii) whether they agreed
that school nurses should be responsible for these vaccina-
tions. The answers were scored as “strongly disagree” = 0,
“partially disagree” = 1, “partially agree” = 2, and “strongly
agree” = 3. The scores from the two questions were added,
resulting in a total score of 0–6, categorised as “positive
attitude” = 6, “ambivalent attitude” = 4–5, and “negative at-
titude” = 0–3.
Of the three main predictors in the present study, per-
ceived knowledge of HPV vaccinations was based on two
questions about whether the school nurses had good
knowledge about HPV to inform (i) the girls and (ii) their
parents or guardians before the vaccination. These were
scored in the same way as for attitude towards HPV
vaccination, with the total score categorised as “high
perceived knowledge” = 6, “ambivalent about perceived
knowledge” = 4–5, and “low perceived knowledge” = 0–3.
Nurses’ education about HPV vaccination was based on
three questions about whether they had received and con-
sidered information from (i) governmental agencies and
(ii) pharmaceutical companies, and (iii) if they had know-
ledge about the campaigns against HPV. These questions
were scored in the same way as for attitude towards HPV
vaccination, resulting in a score of 0–9. Further, an extra
point was added for each of three alternative levels of for-
mal organised training (national, local, individual) they
had received or if they had searched for information on
their own. This resulted in a total score of 0–13 for
education received, with the total score categorised as
“high level of education” = 11–13, “medium level of
education” = 8–10, and “low level of education” = 0–7.
Financial support given to the School Health Services
was categorised into three categories: (i) used to fund
an additional school nurse; (ii) used for other purposes
(to fund extra work time, continuous education, or
equipment); and (iii) not used to cover extra expenses
incurred by the HPV vaccinations.
Statistical analyses
Categorical and ordinal data are presented as frequen-
cies and percentages, n (%), and continuous data as
means and standard deviations (SD). Correlations be-
tween ordinal variables were calculated using Spearman’s
ρ. Univariate tests for differences between the three
groups (“positive”, “ambivalent”, and “negative” attitude
to HPV vaccination) were performed using Pearson’s χ2-
test for categorical and ordinal variables, while analysis
of variance was used for continuous variables. In ana-
lyses using the total score (0–6) of the variable attitude
to HPV vaccination, differences in attitude between two
categories were tested using the Mann–Whitney U test,
while the Kruskal-Wallis test was used to test for differ-
ences between more than two categories.Multinomial logistic regression analysis was used to
study the magnitude of the association between the
three main predictors and the outcome. In the regres-
sion models, “negative attitude” was used as the reference
category for the outcome “attitude to HPV vaccination”.
The regression analyses were performed in two steps.
First, univariate logistic regression analyses were per-
formed for each of the variables with p < 0.2 from the
univariate tests for differences between the three groups
“positive”, “ambivalent”, and “negative” attitude. Second,
all variables with p < 0.2 in the univariate logistic regres-
sion analyses were then simultaneously used in multi-
variate logistic regression analysis to obtain the adjusted
odds ratios (ORs) of the included variables for having
a positive or ambivalent attitude to HPV vaccination
compared with having a negative attitude. The results
of the logistic regression analyses are presented as ORs
with 95% confidence intervals (CIs) and accompanying
p-values.
All statistical analyses were performed using SPSS
Statistics version 20.0 (IBM Corp., Armonk, NY, USA).
In all analyses, two-sided p-values <0.05 were considered
statistically significant.
Results
In total, 83.1% (851/1024) of the school nurses from all
counties in Sweden completed the web-based question-
naire. The characteristics of the participating nurses,
according to their attitudes to HPV vaccination, are pre-
sented in Table 1. There were statistically significant differ-
ences in attitudes to HPV vaccination related to perceived
knowledge about HPV vaccination (p < 0.001) and educa-
tion received about HPV (p < 0.001). Nurses were more
likely to have a positive attitude to vaccination if they had
more knowledge and education about vaccination.
Attitudes to HPV vaccination
In total, 446 nurses (52.4%) had a positive attitude to HPV
vaccination, 314 (36.9%) had an ambivalent attitude, and 91
(10.7%) had a negative attitude (Table 2). The majority of
nurses strongly or partially agreed that it was appropriate that
HPV vaccinations were introduced into the general child-
hood vaccination programme and that school nurses should
be responsible for the vaccinations. Most participants agreed,
strongly or partially, that boys should also be offered the
HPV vaccine in the school-based vaccination programme.
One out of 10 believed that a provider other than the School
Health Services, such as primary care, n = 74 (8.7%) or a vac-
cination agency n = 11 (1.3%), would be more appropriate.
In addition, 574 school nurses (67.5%) considered that it
was appropriate to vaccinate girls aged 10–12 years,
whereas 238 (28.0%) thought that 13–14 years was a more
suitable age, and 39 (4.5%) stated that the vaccine should
be given at ≥ 15 years.
Table 1 Characteristics of the participating school nurses (n = 851) according to attitude to human papillomavirus
(HPV) vaccination
Attitude to HPV vaccination
Variables Positive (n = 446) Ambivalen (n = 314) Negative (n = 91) p-valuea
Age (years), mean (SD) 52.0 (7.7) 51.9 (7.2) 50.6 (7.5) 0.276
Years as a school nurse, mean (SD) 10.6 (7.9) 9.7 (6.6) 9.6 (5.9) 0.190
Sex 0.309b
−Female, n (%) 438 (52.1) 311 (37.0) 91 (10.8)
−Male, n (%) 8 (72.7) 3 (27.3) 0 (0.0)
Employment 0.364
−Public school, n (%) 411 (52.6) 290 (37.1) 80 (10.2)
−Private school, n (%) 35 (50.0) 24 (34.3) 11 (15.7)
Perceived knowledge <0.001
−High 277 (60.1) 152 (33.0) 32 (6.9)
−Ambivalent 120 (42.7) 120 (42.7) 41 (14.6)
−Low 49 (45.0) 42 (38.5) 18 (16.5)
Education received about HPV <0.001
−High 122 (62.2) 67 (34.2) 7 (3.6)
−Medium 290 (52.7) 200 (36.4) 60 (10.9)
−Low 33 (31.7) 47 (45.2) 24 (23.1)
Use of financial support 0.126
−Found an additional school nurse 108 (59.0) 63 (34.4) 12 (6.6)
−Other 32 (51.6) 25 (40.3) 5 (8.1)
−Not used to cover extra expenses 305 (50.4) 226 (37.4) 74 (12.2)
ap-values from ANOVA and Pearson’s χ2-test for categorical and ordinal variables.
bUnreliable because of too few male school nurses included.
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participants (67%) reported difficulties with the HPV vacci-
nations, including some who had encountered more than
one difficulty. We found that 276 of these school nurses
(48.4%) had doubts about vaccination at such a young age,
while 337 (59.1%) considered that the HPV vaccination
programme was time-consuming, and 115 (20.2%) believed
that their workload had increased. They believed that it
would be easier to provide information about HPV infec-
tion if the girls were older and more sexually active and to
motivate parents because most Swedish girls are not sexu-
ally active before the age of 15. Fears of needles and pain
were highlighted by 148 nurses (26.0%), and 85 (14.9%) of
the respondents reported logistical problems with the time
intervals between the three doses. One school nurse
expressed her difficulties as follows: “The HPV vaccinations
increase our workload, because they are very time-
consuming and require a lot of planning. Therefore, it is
challenging to find time for other preventive efforts”.
Received education and perceived knowledge about HPV
Table 3 examines the education the school nurses received
about HPV vaccination and their perceived knowledge
about it. Using total scores, a positive correlation betweenthe nurses’ perceived knowledge about vaccination and a
favourable attitude towards vaccination was found (ρ =
0.191; p < 0.001). There was also a positive correlation be-
tween the education received about HPV vaccination and a
favourable attitude (ρ = 0.025; p < 0.001).
In total, 534 (62.7%) of the respondents received formal
organised training about HPV before the implementation
at a local level, i.e., by their employer. In addition, 565
(66.4%) of the nurses obtained information themselves, 192
(22.6%) participated in formal training organised by the Na-
tional Board of Health and Welfare or other national edu-
cation programmes, and 109 (12.8%) of the nurses received
individual organised training, e.g. by a school physician.
However, 43 (5.1%) of the nurses received no formal orga-
nised education about HPV. The majority, 788 (92.6%),
were content with both the Government’s information and
the information provided by the drug companies.
Information about HPV
Most of the school nurses, 828 (97.3%), sent standardised
written information to the parents, and 175 (20.6%) also
provided information at parental meetings. In addition,
290 of the school nurses (34.1%) provided information by
email or telephone if they were contacted by the parents.









n (%) n (%) n (%) n (%)
It is appropriate that HPV vaccination was introduced into the general childhood
vaccination program.
544 (63.9) 239 (28.6) 54 (6.2) 11 (1.3)
The school nurse should be responsible for the HPV vaccinations. 517 (60.8) 239 (28.1) 68 (8.0) 27 (3.2)
Boys should also be offered the HPV vaccine in the school-based vaccination
program.
352 (41.4) 341 (40.1) 113 (13.3) 45 (5.3)
HPV vaccination is more painful than other vaccinations. 232 (27.3) 302 (35.5) 172 (20.2) 145 (17.0)
Fear of needles is a problem. 198 (23.3) 375 (44.1) 176 (20.7) 102 (12.0)
Those who decline vaccination should be offered the vaccination later. 271 (31.8) 238 (28.0) 184 (21.6) 158 (18.6)
I have sufficient confidence in the authorities’ decisions about HPV vaccination. 393 (46.2) 356 (41.8) 81 (9.5) 21 (2.5)
HPV vaccination may result in decreased condom use. 54 (6.3) 377 (44.3) 257 (30.2) 163 (19.2)
HPV vaccination may result in an increased number of sexual partners. 31 (3.6) 167 (19.6) 335 (39.4) 318 (37.4)
HPV vaccination may improve the awareness of sexually transmitted infections. 199 (23.4) 527 (61.9) 95 (11.2) 30 (3.5)
HPV vaccination may reduce participation in Pap smear tests. 72 (8.5) 466 (54.8) 227 (26.7) 86 (10.1)
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before the vaccination, whereas 262 (30.8%) informed
both girls and boys together, and 123 (14.5%) did not in-
form the pupils verbally before the vaccination. The ma-
jority of the school nurses, 648 (76.1%), were contacted by
parents who had questions about the vaccine. More than
half of these questions, 355 (54.8%), were related to the
adverse effects of the vaccine, while the other queries
raised by parents were concerned with vaccination at such
a young age (122 (18.8%)), and the long-term effects of
the vaccine (85 (13.1%)). Moreover, 86 nurses (13.3%)
were contacted by parents for advice about the vaccin-
ation. One school nurse illustrated a parent’s concerns as
follows: “Is the vaccine reliable, and what are the common
side effects? Is it necessary to vaccinate a girl aged 10–12
or is it possible to wait until she is older?”.
Financial support from the government
No statistically significant differences in attitudes to
HPV vaccination were observed overall in Table 1 for
the different uses of the financial support from the gov-
ernment (p = 0.126). However, an analysis of the totalTable 3 School nurses’ perceived knowledge about HPV vacc
Strongl
n (%)
I have received and considered the Government´s information
about HPV.
661 (77.7
I have received and considered the drug company’s information
about HPV.
476 (55.9
I have knowledge about the campaigns against HPV 461 (54.2
I have good knowledge about HPV to inform parents. 481 (56.5
I have good knowledge about HPV to inform girls. 529 (62.2score (0–6) for attitude to HPV vaccination revealed a
statistically significant (p = 0.044) difference in attitude
due to how the financial support from the Swedish
Government had been used. The nurses who worked at
schools that used the money to fund the costs of an add-
itional school nurse had a significantly (p = 0.014) more
favourable attitude towards HPV vaccination compared
with those who worked at schools where the money was
not used to compensate for the additional expenditure
incurred by the vaccinations. The majority of the partici-
pants, 652 (76.6%), reported that as far as they knew, the
financial support had not been used to cover the extra
expenses incurred by HPV vaccinations. Less than a
quarter, 199 (23.4%), had received financial support, 183
(21.5%) for an additional nurse, and 16 (1.9%) for extra
working time.
Multinomial logistic regression analyses
Tables 4 and 5 present the results from the univariate and
multivariate, respectively, multinomial logistic regression
analyses with attitude to HPV vaccination as outcome. The
number of years as a school nurse, perceived knowledgeination (n = 851)
y agree Partially agree Partially disagree Strongly disagree
n (%) n (%) n (%)
) 136 (16.0) 54 (6.3) 0 (0.0)
) 299 (35.1) 70 (8.2) 6 (0.7)
) 367 (43.1) 23 (2.7) 0 (0.0)
) 296 (34.8) 61 (7.2) 13 (1.5)
) 226 (26.6) 96 (11.3) 0 (0.0)
Table 4 Univariate logistic regression with attitude to HPV vaccination as outcome
Attitude to HPV vaccination
Positivea Ambivalenta
Variable OR (95% CI) p-value OR (95% CI) p-value
Years as a school nurse 1.020 (0.987–1.054) 0.237 1.003 (0.969–1.038) 0.869
Perceived knowledge
−High 3.180 (1.655–6.107) 0.001 2.036 (1.040–3.983) 0.038
−Ambivalent 1.075 (0.563–2.052) 0.826 1.254 (0.650–2.418) 0.498
−Low Ref. Ref.
Education received
−High 12.675 (5.023–31.985) <0.001 4.888 (1.946–12.275) 0.001
−Medium 3.515 (1.939–6.372) <0.001 1.702 (0.962–3.011) 0.067
−Low Ref. Ref.
Use of financial support
−Found an additional school nurse 2.184 (1.141–4.176) 0.018 1.719 (0.878–3.363) 0.113
−Other 1.553 (0.585–4.122) 0.377 1.637 (0.605–4.430) 0.332
−Not used to cover extra expenses Ref. Ref.
aReference category: Negative attitude.
Unadjusted odds ratios (OR) and 95% confidence intervals (CIs).
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and use of financial support from the government all
had p-values <0.2 in the univariate tests for differences
between the three groups “positive”, “ambivalent”, and
“negative” attitude presented in Table 1. Thus, they were
all included in separate univariate logistic regression
analyses. All variables except years as a school nurse
showed a statistically significant association with attitude
to HPV vaccination, and were thus included simultan-
eously in the multivariate logistic regression.
The results from the multivariate logistic regression
model showed a strong positive association betweenTable 5 Multinomial logistic regression with attitude to HPV
Positivea









Use of financial support
−Found an additional school nurse 2.053 (1.051–4.010)
−Other 1.118 (0.410–3.046)
−Not used to cover extra expenses Ref.
aReference category: Negative attitude.education received and attitude to HPV vaccination. Thus,
a school nurse with a high level of education about HPV
vaccination was 9.8 times more likely to have a positive
attitude to HPV vaccination compared with a nurse with a
low level of received education (p < 0.001). Likewise, a
school nurse with a medium level of received education
was 3.2 times more likely to have a positive attitude,
compared with a nurse with a low level of received edu-
cation (p < 0.001). Also perceived knowledge about
HPV vaccination had a positive association with atti-
tude to HPV vaccination, with those having a high
perceived knowledge being 2.5 times more likely tovaccination as outcome (adjusted ORs (95% CIs))
Attitude to HPV vaccination
Ambivalenta
p-value OR (95% CI) p-value
0.006 1.758(0.889–3.474) 0.104
0.813 1.270 (0.654–2.465) 0.480
Ref.
<0.001 4.276 (1.676–10.907) 0.002
<0.001 1.632 (0.910–2.924) 0.100
Ref.
0.035 1.655 (0.837–3.272) 0.147
0.827 1.331 (0.484–3.657) 0.579
Ref.
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level of perceived knowledge (p = 0.006). Finally, if the
financial support from the government was used to fund
an additional school nurse, the school nurse was 2.1 times
more likely to have a positive attitude, compared with
nurses working in schools where financial support was
not used to cover the extra expenses incurred by HPV
vaccination (p = 0.035).
Discussion
To the best of our knowledge, this is the first study to exam-
ine the attitudes and experiences of school nurses regarding
a HPV vaccination programme at the population level.
School nurses have a key role in the success of the im-
plementation of vaccination programmes [10,11]. There-
fore it is crucial that they have adequate knowledge about
HPV and skills to ensure that they feel comfortable with
all the procedures related to the vaccinations. Adequate
knowledge and appropriate ongoing education about HPV
among healthcare professionals (HCPs) are necessary in
order to promote vaccine coverage [14,15]. Thus, the
nurses who had a positive attitude to the HPV vaccina-
tions and were confident with their training were likely to
be more at ease when providing information to parents
and children, managing their concerns and obtaining in-
formed consent. School nurses have a unique position in
informing parents and addressing their questions and con-
cerns (and clarifying any misunderstandings) regarding
HPV vaccination [16,17]. Their communication skills
regarding HPV vaccination are essential to foster parental
acceptance and to promote public health [14]. Recom-
mendations from HCPs are associated with better HPV
vaccine uptake [15,18]. Thus, HCP education and know-
ledge about HPV as well as communication skills are
important since the majority were contacted by parents
who had additional questions about the vaccine, especially
its adverse effects. The necessity for HCPs to discuss vac-
cine safety and effectiveness with parents was also noted
in previous studies [17,19]. The safety profile of the HPV
vaccine is well established, and no severe adverse effects
have been found [20]. Thus, if this information is
highlighted more clearly in the printed information pro-
vided to parents, some of their concerns may be alleviated.
This would also make the task of obtaining informed con-
sent easier for school nurses.
The school nurses perceived that they had an in-
creased workload in implementing the HPV vaccinations
and this was also reported in studies from the United
Kingdom [10,11,21]. The available financial support had
not been used to a great extent to cover the extra ex-
penses for the vaccinations, and therefore it was not sur-
prising that nurses reported difficulties in implementing
the programme because of time constraints. Thus, it is
important to identify strategies to provide direct financialsupport to cover the additional expenditure incurred by
the vaccinations, thereby ensuring the continued success
of the HPV vaccination programme.
The professional role of school nurses includes pre-
serving and promoting health equality [9,11]. This might
have been reflected in the finding that the majority
agreed that boys should also be vaccinated. Other child-
hood vaccinations are offered to both boys and girls, so
the exclusion of boys may be viewed as an ethical di-
lemma, which was also noted by Malmqvist et al.
[22,23]. Another consideration was the attitude to the
age of girls when they received the vaccination, where
one-third of nurses believed that girls should be slightly
older because it would have been easier to provide them
with appropriate information about HPV. A majority of
the school nurses also believed that parents who did not
consent should be offered the option of having their
daughter vaccinated at a later time. This was consistent
with our previous findings about parents not consenting
to vaccination [17]. Nevertheless, there is an ethical di-
lemma of the public health benefit of mass immunisa-
tion versus individual autonomy [24]. Even if it would be
beneficial for an individual family to be offered vaccin-
ation at a later time, this could affect the vaccination
programme and eventually lead to lower vaccination
coverage. In addition, a delay in vaccination might lead
to a decreased health benefit for the individual. There-
fore, it must be emphasised to school nurses that the
reason for vaccinating at such a young age is to give the
best possible protection against HPV. One way to over-
come this is by handling HPV vaccinations like all other
childhood vaccinations, such as measles-mumps-rubella
(MMR) vaccination. Parents who decline the MMR vac-
cine are contacted by the school nurse, and are offered a
second chance to vaccinate. This contact with the school
nurse could also be an opportunity for parents to ask
additional questions about HPV and the HPV vaccine.
However, it is important to emphasise that the vaccine is
prophylactic, and parents should be informed that it
needs to be received before possible exposure to HPV,
i.e., before sexual activity commences.
Strengths and limitations
A major advantage of this study was the high response
rate. School nurses from all 20 counties in Sweden par-
ticipated, and also from both private and public schools,
so the results may be generalised to the whole popula-
tion of school nurses involved in the HPV vaccination
programme in Sweden. One caveat is that we could not
be sure that school nurses from all of the 290 municipal-
ities in Sweden participated in the survey. The use of a
web-based survey allowed many nurses to participate and
to respond within a short period. A possible limitation is
that we could not prove that only school nurses answered
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rected exclusively to school nurses, but personal identifica-
tion was not required before completing the questionnaire.
To overcome this limitation, we checked all the demo-
graphic data to ensure that no school nurses had respon
ded more than once. Another possible limitation is the lack
of information about non-responders.
It would have been interesting to investigate whether the
attitudes of the school nurses correlated with the coverage
rate, but this was not feasible as the data were not available
at the time of preparation of the manuscript. Since January
2013, it has been mandatory to report vaccinations within
the national childhood vaccination programme to the
National Vaccination Registry in Sweden.
Conclusions
The majority of the school nurses were in favour of the
school-based HPV vaccination programme, despite the
increased workload that it incurred. There were an associ-
ation between received education and perceived knowledge
about HPV and a positive attitude to the vaccination
programme. School nurses need adequate resources so that
they can provide information to parents and answer their
questions and concerns. HPV vaccination is a complex and
time-consuming task, which demands knowledge, skills,
time and, ultimately, financial support.
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